To further validate the role of p-ERK1/2 signaling in miR-221-regulated invasion and migration of BC cells, we analyzed the impact of introducing an ERK inhibitor (U0126) into 5637 cells with stable miR-221 overexpression. This evidence concerns the gene MAPK3 and breast cancer.